Smilow Cancer Hospital - New Haven — New Haven, Connecticut

Smilow Cancer Hospital - New Haven is a clinical research site located in New Haven, Connecticut, United States 06511.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Smilow Cancer Hospital - New Haven has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Glioblastoma, Myelofibrosis, Acute Lymphoblastic Leukemia.

Sponsors: Denovo Biopharma LLC, Karyopharm Therapeutics Inc, Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Hospital - New Haven?

Smilow Cancer Hospital - New Haven has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Hospital - New Haven conducted?

Smilow Cancer Hospital - New Haven has 3 clinical trials on record, with 1 currently active. Their work covers Glioblastoma, Myelofibrosis, Acute Lymphoblastic Leukemia.

Is Smilow Cancer Hospital - New Haven accredited by Crixeo Health?

Smilow Cancer Hospital - New Haven has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Smilow Cancer Hospital - New Haven?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.